To study the potential relationship between PHD2 expression and patient survival, we first sorted The Cancer Genome Atlas (TCGA) skin cutaneous melanoma (SKCM) patients into PHD2-high and PHD2-low groups according to PHD2 messenger RNA (mRNA) expression levels. Here, EGLN1 is linked to cutaneous melanoma.